About Contact Us Careers
Sign In

Non Invasive Prenatal Testing Market Analysis

  • Report ID: 6309
  • Published Date: Aug 08, 2024
  • Report Format: PDF, PPT
  1. An Outline of the Global Non-Invasive Prenatal Testing (NIPT) Market
    1. Study Objective
    2. Market Definition
    3. Market Segmentation
  1. Assumptions and Abbreviations
  2. Research Process
    1. SPSS Methodology
    2. Primary Research
      1. Manufacturers
      2. End Users
    3. Secondary Research
    4. Market Size Estimation
  3. Executive Summary
  4. Opportunities
  5. Growth Drivers
  6. Major Roadblocks
  7. Trends
  8. Government Regulation: How They Would Aid Business?
  9. Up-Coming Technologies
  10. Growth Outlook
  11. Risk Analysis
  12. SWOT
  13. Merger and Acquisitions
  14. Application Analysis
  15. Regional Demand
  16. Recent News
  17. Technology Analysis
  18. End User Analysis
  19. Non-Invasive Prenatal Testing (NIPT) Uptake by Pregnancy Risk Level Analysis
  20. Comparative Positioning
  21. Competitive Landscape: Global Key Players
    1. Company Market Share
    2. Business Profile of Key Enterprise
      1. Centogene N.V.
        1. Detailed Overview
        2. Assessment of key offerings
        3. Analysis of growth strategies
        4. Exhaustive analysis on key financial indicators
        5. Recent developments and strategies
      2. CRIFM Prenatal Medical Clinic
      3. Eurofins LifeCodexx GmbH
      4. MedGenome Labs Ltd.
      5. NIPT Hiro Clinic
      6. FALCO biosystems Ltd.
      7. Biora Therapeutics,Inc.(Progenity,Inc.)
      8. F. Hoffmann-La Roche Ltd.
      9. Illumina Inc.
      10. Laboratory Corporation of America Holdings.
      11. Natera Inc.
      12. Myriad Women’s Health, Inc.
      13. QIAGEN
      14. Quest Diagnostics
      15. CooperSurgical, Inc. 
  22. Global Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Global Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical Screening Tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma Testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End user
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Region
        1. North America Market Value (USD Million), and CAGR, 2024-2037F
        2. Europe Market Value (USD Million), and CAGR, 2024-2037F
        3. Asia Pacific Excluding Japan Market Value (USD Million), and CAGR, 2024-2037F
        4. Japan Market Value (USD Million), and CAGR, 2024-2037F
        5. Latin America Market Value (USD Million), and CAGR, 2024-2037F
        6. Middle East and Africa Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037   

  1. North America Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. North America Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End user
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. US Market Value (USD Million), and CAGR, 2024-2037F
        2. Canada Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037 

  1. Europe Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Europe Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End User
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. UK Market Value (USD Million), and CAGR, 2024-2037F
        2. Germany Market Value (USD Million), and CAGR, 2024-2037F
        3. France Market Value (USD Million), and CAGR, 2024-2037F
        4. Italy Market Value (USD Million), and CAGR, 2024-2037F
        5. Spain Market Value (USD Million), and CAGR, 2024-2037F
        6. BENELUX Market Value (USD Million), and CAGR, 2024-2037F
        7. Poland Market Value (USD Million), and CAGR, 2024-2037F
        8. Russia Market Value (USD Million), and CAGR, 2024-2037F
        9. Rest of Europe Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037  

  1. Asia Pacific excluding Japan Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Asia Pacific excluding Japan Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End User
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. China Market Value (USD Million), and CAGR, 2024-2037F
        2. India Market Value (USD Million), and CAGR, 2024-2037F
        3. ASEAN, Market Value (USD Million), and CAGR, 2024-2037F
        4. South Korea Market Value (USD Million), and CAGR, 2024-2037F
        5. Australia Market Value (USD Million), and CAGR, 2024-2037F
        6. New Zealand Market Value (USD Million), and CAGR, 2024-2037F
        7. Rest of Asia Pacific excluding Japan Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

  1. Japan Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Japan Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma Testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End User
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

  1. Latin America Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Latin America Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End user
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. Brazil Market Value (USD Million), and CAGR, 2024-2037F
        2. Argentina Market Value (USD Million), and CAGR, 2024-2037F
        3. Mexico Market Value (USD Million), and CAGR, 2024-2037F
        4. Rest of Latin America Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End user W.R.T. Technology (USD Million), 2024-2037

  1. Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End user
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. GCC Market Value (USD Million), and CAGR, 2024-2037F
        2. Israel Market Value (USD Million), and CAGR, 2024-2037F
        3. South Africa Market Value (USD Million), and CAGR, 2024-2037F
        4. Rest of Middle East & Africa Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037   

  1. Global Economic Scenario

Non Invasive Prenatal Testing Market Analysis

Gestational Age (0-12 weeks, 13-24 weeks, 25–36 weeks)

13-24 weeks segment is poised to account for non invasive prenatal testing market share of more than 51.4% by the end of 2037. It is anticipated to continue dominating other segments with a strong CAGR of 9.5% from 2025 to 2037. The segment is leading as detection in the second trimester provides an optimal window between detection and test accuracy. This timeframe is also easily combined with other crucial prenatal screening tests, such as ultrasound and serum screening for alpha-fetoprotein.

A recent development related to this was by Illumina, Inc. in January 2024 when they launched VeriSeq NIPT Solution v2. This new solution enables the test to detect partial deletions and duplications of all chromosomes with the test, greatly enhancing its power to recognize a wider range of genetic anomalies during these critical weeks from 13-24.

Method (Biochemical screening tests, Maternal cell-free DNA, Plasma testing, Ultrasonic Detection)

The maternal cell-free DNA segment in non invasive prenatal testing market dominated the revenue in 2024 and is projected to continue with a 9.6% CAGR from 2025 to 2037. The growth of the segment is propelled by technological advancements that extend the testing capabilities to whole genome sequencing for the detection of microdeletions and sex chromosomal abnormalities. Increasing product launches and improving reimbursement scenarios also contribute to NIPT market growth and both, directly and indirectly make these tests accessible to a larger population.

As per a report from the National Institutes of Health in August 2023, the adoption rate for cfDNA-based NIPT is over 75% among pregnant women in high-income countries. This represents an increase of 15% from that reported in 2022 and outlines the acceptance and integration of NIPT into standard prenatal care protocols. To tap into the opportunity, companies are launching various innovative tests.

For example, in March 2024, Roche announced the launch of its HARMONY prenatal test with expanded capabilities. Innovations like these from companies enable extra rare chromosomal conditions, allowing more inclusively rounded insight into fetal health during pregnancy.

Our in-depth analysis of the global non invasive prenatal testing market includes the following segments:

     Gestational Age
  • 0-12 weeks 
  • 13-24 weeks 
  • 25–36 weeks

     Pregnancy Risk
  • High risk vs. average risk 
  • Low risk

     Method
  • Biochemical screening tests 
  • Maternal cell-free DNA 
  • Plasma testing
  • Ultrasonic Detection

     Technology
  • Next-generation sequencing (NGS) 
  • Array Technology
  • Polymerase Chain Reaction (PCR)

     Product
  • Consumables and Reagents 
  • Device

     Application
  • Trisomy 
  • Microdeletion syndromes 
  • Other

     End user
  • Hospitals and Clinics 
  • Diagnostic Laboratories
Get more information on this report: Request Free Sample PDF
Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar


  • Report ID: 6309
  • Published Date: Aug 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In 2024, the industry size of non invasive prenatal testing (NIPT) was USD 4.5 billion.

The global non invasive prenatal testing (NIPT) market size is projected to reach USD 4.5 billion in 2024 and is expected to secure USD 14.5 billion by the end of 2037, expanding at a CAGR of 9.4% during the forecast period, i.e., 2025-2037. In 2025, the industry size of non invasive prenatal testing (NIPT) will be valued at USD 4.9 billion.

Key players in the market are Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, and Natera, Inc.

The 13-24 weeks category is likely to hold the largest share of about 51.4% during 2025-2037.

North America is anticipated to provide lucrative prospects for expansion to the companies in the non invasive prenatal testing (NIPT) sector in the coming years.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample